Delivery Order SPE2DB22D2007-SPE2DB25FJ2MJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packages) with a ceiling value of $97,475.68. This firm fixed price delivery order, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) on September 16, 2025, with a ceiling value of $48,737.84 and completion date of October 7, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The performance location is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $73,106.76. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a ceiling value of $24,403.80. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Ayvakit 25 mg tablets in a quantity of 30 units, with a ceiling value of $25,681.09 and firm fixed pricing. This competitive, non-set-aside delivery order is scheduled for completion by November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child award issued under AmerisourceBergen's larger indefinite...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ayvakit 25 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $48,737.84, represents a non-set-aside competitive award and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $24,369 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2MJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $24,368.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. This procurement reflects the company's established role as a critical vendor within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 6/25/25 |